back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-09-16 Tx date 2015-09-25 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Holder: Remedis Health Care Inc. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$20,000
+50,000 vol $0.40 each |
||
| Filed 2016-09-16 Tx date 2015-09-25 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Holder: Remedis Health Care Inc. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$20,000
+50,000 vol $0.40 each |
250,000 | |
| Filed 2016-09-15 Tx date 2015-09-25 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Holder: Remedis Health Care Inc. (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$20,000
+50,000 vol $0.40 each |
250,000 | |
| Filed 2016-09-15 Tx date 2015-09-25 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Holder: Remedis Health Care Inc. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-20,000
-50,000 vol $0.40 each |
0 | |
| Filed 2016-09-15 Tx date 2015-09-25 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Holder: Remedis Health Care Inc. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-20,000
-50,000 vol $0.40 each |
||
| Filed 2016-09-15 Tx date 2015-09-25 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Holder: Remedis Health Care Inc. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-20,000
-50,000 vol $0.40 each |
||
| Filed 2016-03-04 Tx date 2016-02-29 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Holder: Remedis Health Care Inc. (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+100,000 vol $0.10 each |
300,000 | |
| Filed 2016-02-26 Tx date 2016-02-26 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,000
+50,000 vol $0.10 each |
200,290 | |
| Filed 2016-02-15 Tx date 2015-12-31 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Holder: Sunlife (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$20,542
+60,596 vol $0.339 each |
322,207 | |
| Filed 2016-02-15 Tx date 2015-12-31 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Taillefer, Myriam
5 - Senior Officer of Issuer
Holder: Sunlife Canada (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$10,831
+32,045 vol $0.338 each |
37,866 | |
| Filed 2016-02-15 Tx date 2015-12-31 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Olds, Donald John
5 - Senior Officer of Issuer
Holder: Sunlife Canada (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,856
+46,774 vol $0.339 each |
106,503 | |
| Filed 2016-02-15 Tx date 2015-12-31 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Gratton, André
5 - Senior Officer of Issuer
Holder: Sunlife Canada (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,081
+44,620 vol $0.338 each |
107,249 | |
| Filed 2016-02-15 Tx date 2015-12-31 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Holder: Sunlife Canada (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,648
+13,753 vol $0.338 each |
33,057 | |
| Filed 2016-02-15 Tx date 2015-12-31 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Boudreau, Mathieu
5 - Senior Officer of Issuer
Holder: Sunlife Canada (Indirect Ownership)
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,944
+20,426 vol $0.34 each |
40,992 | |
| Filed 2015-12-07 Tx date 2015-12-07 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+50,000 vol $0.30 each |
50,000 | |
| Filed 2015-12-07 Tx date 2015-08-06 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-12-07 Tx date 2015-12-07 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Olds, Donald John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,000
+50,000 vol $0.30 each |
252,159 | |
| Filed 2015-12-04 Tx date 2015-12-02 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$990.00
+3,000 vol $0.33 each |
12,000 | |
| Filed 2015-12-03 Tx date 2015-12-02 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,145
+6,500 vol $0.33 each |
9,000 | |
| Filed 2015-12-03 Tx date 2015-12-02 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$812.50
+2,500 vol $0.325 each |
2,500 | |
| Filed 2015-12-03 Tx date 2010-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-11-19 Tx date 2015-02-17 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Gratton, André
5 - Senior Officer of Issuer
Holder: hold through his wife (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-11-19 Tx date 2015-11-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Gratton, André
5 - Senior Officer of Issuer
Holder: hold through his wife (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,975
+2,500 vol $0.79 each |
2,500 | |
| Filed 2015-11-18 Tx date 2014-10-20 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Taillefer, Myriam
5 - Senior Officer of Issuer
Holder: Detenues par son mari (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-11-18 Tx date 2015-11-17 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Taillefer, Myriam
5 - Senior Officer of Issuer
Holder: Detenues par son mari (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,212
+5,200 vol $0.81 each |
5,200 | |
| Filed 2015-11-18 Tx date 2015-11-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$30,020
+38,000 vol $0.79 each |
155,474 | |
| Filed 2015-11-16 Tx date 2015-11-12 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$82,000
+100,000 vol $0.82 each |
225,000 | |
| Filed 2015-11-16 Tx date 2015-11-12 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$82,000
+100,000 vol $0.82 each |
150,000 | |
| Filed 2015-11-16 Tx date 2015-11-12 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$82,000
+100,000 vol $0.82 each |
350,000 | |
| Filed 2015-11-16 Tx date 2015-11-12 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$82,000
+100,000 vol $0.82 each |
225,000 | |
| Filed 2015-10-09 Tx date 2015-10-07 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$840,000
+2,000,000 vol $0.42 each |
2,000,000 | |
| Filed 2015-10-09 Tx date 2015-10-01 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-09 Tx date 2015-10-01 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Groch, Brian James
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$800,000
+2,000,000 vol $0.40 each |
||
| Filed 2015-09-28 Tx date 2015-09-25 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Holder: Remedis Health Care Inc. (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-20,000
-50,000 vol $0.40 each |
0 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$20,750
+50,000 vol $0.415 each |
50,000 | |
| Filed 2015-09-14 Tx date 2015-08-06 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Whitehead, Warren
4 - Director of Issuer
Direct Ownership
|
Options common
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Taillefer, Myriam
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$41,500
+100,000 vol $0.415 each |
200,000 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$41,500
+100,000 vol $0.415 each |
250,000 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$42,000
+100,000 vol $0.42 each |
||
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Olds, Donald John
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$622,500
+1,500,000 vol $0.415 each |
3,200,000 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Olds, Donald John
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$630,000
+1,500,000 vol $0.42 each |
||
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Gratton, André
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$83,000
+200,000 vol $0.415 each |
350,000 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$31,125
+75,000 vol $0.415 each |
125,000 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$103,750
+250,000 vol $0.415 each |
510,000 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Ford, Brian Douglas
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$105,000
+250,000 vol $0.42 each |
||
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$145,250
+350,000 vol $0.415 each |
610,000 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Champagne, Monique
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$147,000
+350,000 vol $0.42 each |
||
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Boudreau, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$415,000
+1,000,000 vol $0.415 each |
1,400,000 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Boudreau, Mathieu
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$420,000
+1,000,000 vol $0.42 each |
||
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Berendt, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$622,500
+1,500,000 vol $0.415 each |
5,850,000 | |
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Berendt, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$630,000
+1,500,000 vol $0.42 each |
||
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$31,500
+75,000 vol $0.42 each |
||
| Filed 2015-09-14 Tx date 2015-09-09 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Options common
50 - Grant of options
|
$31,125
+75,000 vol $0.415 each |
125,000 | |
| Filed 2015-08-20 Tx date 2015-08-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$39,999
+117,474 vol $0.3405 each |
117,474 | |
| Filed 2015-08-20 Tx date 2015-08-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Rae, James Moodie
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$17,025
+50,000 vol $0.3405 each |
184,740 | |
| Filed 2015-08-20 Tx date 2015-08-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Olds, Donald John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$27,975
+82,159 vol $0.3405 each |
202,159 | |
| Filed 2015-08-20 Tx date 2015-08-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Holder: Claude Perrotte (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$45,000
+132,159 vol $0.3405 each |
132,159 | |
| Filed 2015-08-20 Tx date 2013-11-05 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Holder: Claude Perrotte (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-20 Tx date 2015-08-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Fortin, Lyne
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$34,999
+102,790 vol $0.3405 each |
150,290 | |
| Filed 2015-08-20 Tx date 2015-08-18 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Berendt, Michael Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$49,994
+190,602 vol $0.2623 each |
310,602 | |
| Filed 2015-08-20 Tx date 2013-11-05 |
$TST
Telesta Therapeutics Inc. (formerly known as, Bioniche Life Sciences Inc.) |
Bastien, Yvon
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|